The PlumeStars Research Company (www.plumestars.com), based in Parma, is dedicated to the development of orphan products for rare diseases with a specific know-how in inhalation formulations.
PlumeStars has four important and innovative formulations in its portfolio for the treatment of different orphan diseases and has several international patents for the creation of inhalation powders.
Through this partnership, Neupharma wishes to accelerate the development of its drug portfolio for rare diseases.